BELL & LINDSAY, INC.

Lobbying for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC · treatment of metabolic disorders, including diabetes.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $15,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Accounting

education around MSII's value proposition to treat metabolic health disorders.

Health Issues

education around MSII's value proposition to treat metabolic health disorders.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.